查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606708

數位生物製造市場：按部署、應用和最終用途分類 - 2025-2030 年全球預測

Digital Biomanufacturing Market by Deployment (Cloud, On-premises), Application (Antibodies, Cell & Gene Therapies, Proteins), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位生物製造市場規模為173.5億美元，預計2024年將達到189.7億美元，複合年成長率為9.67%，2030年將達331.2億美元。

數位生物製造是指將數位技術融入藥品、生質燃料和其他生物化學品等生物製品的生產過程中。這種整合提高了效率、精度和擴充性，縮小了傳統生物技術與工業 4.0 之間的差距。對數位生物製造的需求源於對個人化醫療、永續生產技術以及生物製程快速創新的日益成長的需求，以應對全球健康挑戰。其應用涵蓋製藥、農業、食品和飲料以及環境科學，並正在推動即時製程監控和預測分析的進步。最終用戶範圍從製藥公司到農業和能源部門。關鍵成長要素包括資料分析、機器學習和自動化方面的技術進步，以及對生物技術的投資增加和政府對永續生產方法的支持。個人化醫療領域充滿機遇，數位生物製造可以最佳化客製化治療的生產。為了利用這些機會，企業應專注於發展強大的數位基礎設施並促進跨部門合作。然而，這個市場面臨著挑戰​​，包括技術實施的初始成本高昂、資料隱私問題以及生物技術和數位技術方面缺乏熟練人才。透過有針對性的人才發展和策略夥伴關係關係來解決這些限制至關重要。創新的關鍵領域包括使用人工智慧的生物製程最佳化、使用物聯網的生物製造工作流程以及提高生物技術供應鏈透明度的區塊鏈。研究和開發應側重於降低營運成本並提高產品產量比率和品質。市場的本質是動態和競爭的，快速的技術進步正在不斷重塑行業標準。相關人員必須保持敏捷，適應監管環境和技術創新的變化，以在不斷變化的環境中保持成長和競爭力。

主要市場統計
基準年[2023] 173.5億美元
預計年份 [2024] 189.7億美元
預測年份 [2030] 331.2億美元
複合年成長率（%） 9.67%

市場動態：揭示快速發展的數位生物製造市場的關鍵市場洞察

數位生物製造市場正在因供需的動態相互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 數位生物製造製程的重要應用
    • 對生技藥品的需求不斷增加以及加強生物製造過程的必要性
    • 擴大生物製造設施營運
  • 市場限制因素
    • 部署數位生物製造技術需要高額的成本
  • 市場機會
    • 巨量資料數位雙胞胎在生物製造中的新作用
    • 增加政府對智慧工廠發展的措施和投資
  • 市場挑戰
    • 與數位生物製造相關的遷移和網路安全挑戰

波特五力戰略工具引領數位生物製造市場

波特的五力架構是了解數位生物製造市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解數位生物製造市場的外部影響

外部宏觀環境因素在塑造數位生物製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解數位生物製造市場的競爭狀況

數位生物製造市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣數位生物製造市場供應商績效評估

FPNV定位矩陣是評估數位生物製造市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製數位生物製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，數位生物製造市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 數位生物製造製程的重要應用
      • 對生技藥品的需求不斷增加以及加強生物製造過程的必要性
      • 擴大生物製造設施營運
    • 抑制因素
      • 引進數位生物製造技術成本高昂
    • 機會
      • 巨量資料數位雙胞胎在生物製造中的新作用
      • 增加政府對智慧工廠發展的承諾與投資
    • 任務
      • 與數位生物製造相關的遷移和網路安全挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章數位生物製造市場：依發展分類

  • 雲
  • 本地

第7章數位生物製造市場：依應用分類

  • 抗體
  • 細胞/基因治療
  • 蛋白質
  • 疫苗

第8章數位生物製造市場：依最終用途分類

  • 學術研究所
  • 生物製藥公司
  • 合約調查機構

第9章美洲數位生物製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區數位化生物製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲數位生物製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • ABB Ltd.
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bota Biosciences, Ltd.
  • CellPort Software
  • Culture Biosciences, Inc.
  • Cytiva（Global Life Sciences Solutions USA LLC）
  • Debut Biotechnology
  • Donaldson Company, Inc.
  • Emerson Electric Co.
  • FabricNano
  • GE Healthcare
  • Indegene Limited
  • OVO Biomanufacturing
  • Samsung Biologics
  • Sanofi SA
  • Sartorius AG
  • Shimadzu Corp.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  • 64xBio
Product Code: MRR-5C6F41F5AF44

The Digital Biomanufacturing Market was valued at USD 17.35 billion in 2023, expected to reach USD 18.97 billion in 2024, and is projected to grow at a CAGR of 9.67%, to USD 33.12 billion by 2030.

Digital biomanufacturing refers to the integration of digital technologies into the production processes of biological products, such as pharmaceuticals, biofuels, and other biochemicals. This integration enhances efficiency, precision, and scalability, bridging the gap between traditional biotechnology and Industry 4.0. The necessity for digital biomanufacturing arises from the growing demand for personalized medicine, sustainable production techniques, and the need for rapid innovation in bioprocessing to meet global health challenges. Its applications are vast, encompassing pharmaceuticals, agriculture, food and beverage, and environmental sciences, facilitating advancements like real-time process monitoring and predictive analytics. Ultimate end-users are diverse, ranging from pharmaceutical companies to agricultural and energy sectors. Key growth factors include technological advancements in data analytics, machine learning, and automation, as well as increased investments in biotechnology and governmental support for sustainable production methods. Opportunities abound in personalized medicine, where digital biomanufacturing can optimize production for tailored therapies. Companies should focus on developing robust digital infrastructures and fostering collaborations across sectors to capitalize on these opportunities. However, the market faces challenges such as high initial costs of technology implementation, data privacy concerns, and a shortage of skilled personnel competent in both biotechnology and digital technologies. Addressing these limitations through targeted workforce development and strategic partnerships will be crucial. Critical areas for innovation include artificial intelligence-driven bioprocess optimization, IoT-based biomanufacturing workflows, and blockchain for supply chain transparency in biotech. Research and development should focus on reducing operational costs and enhancing product yield and quality. The nature of the market is dynamic and highly competitive, with rapid technological advancements continually reshaping industry standards. Stakeholders must remain agile, adapting to both regulatory changes and technological innovations to sustain growth and competitiveness in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 17.35 billion
Estimated Year [2024] USD 18.97 billion
Forecast Year [2030] USD 33.12 billion
CAGR (%) 9.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Biomanufacturing Market

The Digital Biomanufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant applications of the digital biomanufacturing process
    • Increased demand for biologics and need for enhanced biomanufacturing process
    • Expanding operations of biomanufacturing facilities
  • Market Restraints
    • High costs required for the deployment of digital biomanufacturing technologies
  • Market Opportunities
    • Emerging roles of big data and digital twin in biomanufacturing
    • Growing government initiatives and investments in smart factory development
  • Market Challenges
    • Transition and cybersecurity challenges associated with digital biomanufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Digital Biomanufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Biomanufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Biomanufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Biomanufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Biomanufacturing Market

A detailed market share analysis in the Digital Biomanufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Biomanufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Biomanufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Biomanufacturing Market

A strategic analysis of the Digital Biomanufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ABB Ltd., Agilent Technologies, Inc., bioMerieux SA, Bota Biosciences, Ltd., CellPort Software, Culture Biosciences, Inc., Cytiva (Global Life Sciences Solutions USA LLC), Debut Biotechnology, Donaldson Company, Inc., Emerson Electric Co., FabricNano, GE Healthcare, Indegene Limited, OVO Biomanufacturing, Samsung Biologics, Sanofi SA, Sartorius AG, Shimadzu Corp., Siemens AG, Thermo Fisher Scientific Inc., Waters Corp., and 64xBio.

Market Segmentation & Coverage

This research report categorizes the Digital Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Deployment, market is studied across Cloud and On-premises.
  • Based on Application, market is studied across Antibodies, Cell & Gene Therapies, Proteins, and Vaccines.
  • Based on End-use, market is studied across Academic & Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant applications of the digital biomanufacturing process
      • 5.1.1.2. Increased demand for biologics and need for enhanced biomanufacturing process
      • 5.1.1.3. Expanding operations of biomanufacturing facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High costs required for the deployment of digital biomanufacturing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging roles of big data and digital twin in biomanufacturing
      • 5.1.3.2. Growing government initiatives and investments in smart factory development
    • 5.1.4. Challenges
      • 5.1.4.1. Transition and cybersecurity challenges associated with digital biomanufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Biomanufacturing Market, by Deployment

  • 6.1. Introduction
  • 6.2. Cloud
  • 6.3. On-premises

7. Digital Biomanufacturing Market, by Application

  • 7.1. Introduction
  • 7.2. Antibodies
  • 7.3. Cell & Gene Therapies
  • 7.4. Proteins
  • 7.5. Vaccines

8. Digital Biomanufacturing Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Biopharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Digital Biomanufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Biomanufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomanufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. ABB Ltd.
  • 3. Agilent Technologies, Inc.
  • 4. bioMerieux SA
  • 5. Bota Biosciences, Ltd.
  • 6. CellPort Software
  • 7. Culture Biosciences, Inc.
  • 8. Cytiva (Global Life Sciences Solutions USA LLC)
  • 9. Debut Biotechnology
  • 10. Donaldson Company, Inc.
  • 11. Emerson Electric Co.
  • 12. FabricNano
  • 13. GE Healthcare
  • 14. Indegene Limited
  • 15. OVO Biomanufacturing
  • 16. Samsung Biologics
  • 17. Sanofi SA
  • 18. Sartorius AG
  • 19. Shimadzu Corp.
  • 20. Siemens AG
  • 21. Thermo Fisher Scientific Inc.
  • 22. Waters Corp.
  • 23. 64xBio

LIST OF FIGURES

  • FIGURE 1. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL BIOMANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023